FT, M., I, S. R., R, L., G, R., R, B., L, E., . . . L, G. (2021). Scientific and regulatory evaluation of mechanistic in silico drug and disease models in drug development: Building model credibility. CPT: pharmacometrics & systems pharmacology, 10(8), 804. https://doi.org/10.1002/psp4.12669
Chicago Style (17th ed.) CitationFT, Musuamba, et al. "Scientific and Regulatory Evaluation of Mechanistic in Silico Drug and Disease Models in Drug Development: Building Model Credibility." CPT: Pharmacometrics & Systems Pharmacology 10, no. 8 (2021): 804. https://doi.org/10.1002/psp4.12669.
MLA (9th ed.) CitationFT, Musuamba, et al. "Scientific and Regulatory Evaluation of Mechanistic in Silico Drug and Disease Models in Drug Development: Building Model Credibility." CPT: Pharmacometrics & Systems Pharmacology, vol. 10, no. 8, 2021, p. 804, https://doi.org/10.1002/psp4.12669.